WHO announces final Ebola vaccine trial results

Public health teams used community-wide treatment and surveillance.

A dated statement recognized India’s introduction of vaccine against a major cause of childhood diarrhoea.

The new immunization option aimed to reduce severe rotavirus disease in children.

Early introduction covered selected states before wider expansion.

Immunization complements clean water, hygiene, and treatment of dehydration.

Participants, health workers and contact-tracing teams made the outbreak trial possible.

The trial offered vaccine to people linked to new Ebola cases to study whether infection could be prevented.

The published results came after the major outbreak and informed later prevention efforts.

A partnership aimed to make paediatric benznidazole more accessible.

Early detection and therapy are important for infected children in affected regions.